![]()
Even before morbidly overweight people lose pounds through gastric bypass surgery — within only a couple days of the procedure — they shed obesity-related diabetes.
Tagging the phenomenon to a specific hormone led to the founding 10 years ago of NGM Biopharmaceuticals Inc. The company developed its own version of the hormone, engineering out the hormone's connection to a higher risk of liver cancer.
Trending: Meet the 130 Best Places to Work in the Bay Area 2017
But instead of pushing forward…